Amphotericin B dose optimization in children with malignant diseases

Chemotherapy. 2007;53(2):142-7. doi: 10.1159/000100013. Epub 2007 Feb 19.

Abstract

In this study, rational dosing guidelines for amphotericin B-deoxycholate (AmB) are proposed for children. AmB steady-state trough concentrations (C(ss,trough)) and plasma creatinine concentrations (C(creat)) were measured in 83 children (age: 10 months to 18 years) receiving prophylactic AmB therapy (1 mg/kg/day). Maximum tolerable AmB C(ss,trough) were identified by determining the probability of large (>24%, 75th percentile) increases in C(creat) after 6 days of AmB for a series of C(ss,trough) ranges. Dose requirements were determined using a concentration-targeting approach. The 0.76-1.05 mg/l C(ss,trough) range provided the maximum concentrations that still had a low probability (p < 0.29) of adverse renal effects. 1 mg/kg/day AmB produces C(ss,trough) within this range for children weighing 25-45 kg. Lighter children (10-25 kg) require higher AmB doses (1.25-1.5 mg/kg/day) to achieve target C(ss,trough), while heavier children (45-55 kg) require lower doses (0.75 mg/kg/day). These starting dose guidelines may require individualization and prospective evaluation.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amphotericin B / administration & dosage*
  • Amphotericin B / blood
  • Amphotericin B / pharmacokinetics
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / blood
  • Antifungal Agents / pharmacokinetics
  • Body Weight
  • Child
  • Child, Preschool
  • Computer Simulation
  • Creatinine / blood
  • Cyclosporine / therapeutic use
  • Deoxycholic Acid / administration & dosage*
  • Deoxycholic Acid / blood
  • Deoxycholic Acid / pharmacokinetics
  • Drug Combinations
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Kidney Diseases / etiology
  • Kidney Diseases / prevention & control*
  • Microbial Sensitivity Tests
  • Models, Biological
  • Mycoses / prevention & control
  • Neoplasms / blood
  • Neoplasms / drug therapy*
  • Risk Factors
  • Urea / blood
  • gamma-Glutamyltransferase / blood

Substances

  • Antifungal Agents
  • Drug Combinations
  • Immunosuppressive Agents
  • Deoxycholic Acid
  • Amphotericin B
  • Cyclosporine
  • amphotericin B, deoxycholate drug combination
  • Urea
  • Creatinine
  • gamma-Glutamyltransferase